This is why Covid-19 could be life-threatening for some patients
“It looks like this virus has one big trick,” said Shane Crotty, a professor in the Center for Infectious Disease and Vaccine Research at the La Jolla Institute for Immunology in California. (Source: The Economic Times)
Source: The Economic Times - September 25, 2020 Category: Consumer Health News Source Type: news

Health Care of the Future 2020: An OHSU doctor on why Covid is a 'kick in the tush'
Those who work in the field of infectious diseases were not surprised by the pandemic. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Health Care of the Future 2020: An OHSU doctor on why Covid is a 'kick in the tush'
Those who work in the field of infectious diseases were not surprised by the pandemic. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 24, 2020 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news

Health Care of the Future 2020: Dr. Paul Cieslak, Oregon's medical director for Communicable Diseases
Dr. Paul Cieslak keeps a close watch on immunization rates and emerging infectious diseases. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Health Care of the Future 2020: Dr. Paul Cieslak, Oregon's medical director for Communicable Diseases
Dr. Paul Cieslak keeps a close watch on immunization rates and emerging infectious diseases. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 24, 2020 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news

FDA OKs First Point-of-Care Antibody Test for COVID-19 FDA OKs First Point-of-Care Antibody Test for COVID-19
The Assure COVID-19 IgG/IgM Rapid Test Device can now be used in doctors'offices, hospitals, urgent care centers, and emergency departments to provide immediate results.FDA Approvals (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - September 24, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Alert Source Type: news

Trump ’ s Vaccine Czar Refuses to Give Up Stock in Drug Company Trump ’ s Vaccine Czar Refuses to Give Up Stock in Drug Company
The administration calls Moncef Slaoui, who leads its vaccine race, a"contractor" to sidestep rules against personally profiting from government positions.ProPublica (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - September 24, 2020 Category: Infectious Diseases Tags: Public Health & Prevention News Source Type: news

Positive About Flying? Airlines Look to COVID Tests That Give Results in Minutes Positive About Flying? Airlines Look to COVID Tests That Give Results in Minutes
European airlines are pinning hopes on pre-flight COVID-19 tests that deliver results as fast as pregnancy tests to help restore passengers'confidence in taking to the skies in confined spaces with shared air.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - September 24, 2020 Category: Pathology Tags: Infectious Diseases News Source Type: news

We won't beat Covid by channelling Churchill | Letters
Boris Johnson ’s Churchillian language does not impressRichard Teverson, whileKatherine Arnott dismisses the prime minister ’s appeal to people’s common sense. Plus letters fromPatrick Cosgrove andDavid Boyd HaycockI, like so many others, am slack-jawed at the incompetence of this government ’s response to Covid. Our death rate is terrible and the continued mixed messages from “go to work as you are less likely to be sacked if you are in the office/don’t go to work” and “eat out to help out/don’t eat out, certainly not after 10pm” have exhausted the public and mak...
Source: Guardian Unlimited Science - September 24, 2020 Category: Science Authors: Letters Tags: Coronavirus outbreak Infectious diseases Boris Johnson Dominic Cummings Winston Churchill Medical research Politics Microbiology UK news World news Science Michael Gove Brexit Australia news New Zealand Asia Pacific Europea Source Type: news

Fauci Pushes Back on Herd Immunity at Senate Hearing Fauci Pushes Back on Herd Immunity at Senate Hearing
Federal officials, including Fauci, and the FDA and CDC chiefs, also sought to reassure senators and the American public that any COVID-19 vaccine approved for US distribution will be safe.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 24, 2020 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

Coronavirus continuing to mutate, study finds, as US cases rise
Experts believe virus is probably becoming more contagious but US study did not find mutations made it more lethal The Covid-19 virus is continuing to mutate throughout the course of the pandemic, with experts believing it is probably becoming more contagious, as coronavirus cases in the US have started to rise once again, according to new research.The new US study analyzed 5,000 genetic sequences of the virus, which has continued to mutate as it has spread through the population. The study did not find that mutations of the virus have made it more lethal or changed its effects, even as it may be becoming easier to catch, ...
Source: Guardian Unlimited Science - September 24, 2020 Category: Science Authors: Lauren Aratani in New York Tags: Coronavirus outbreak US news Infectious diseases Science Medical research World news Source Type: news

OB/GYN Resident on ECMO for COVID-19 Dies at 28 OB/GYN Resident on ECMO for COVID-19 Dies at 28
Hospitalized for 2 months in Houston, she developed a massive intracranial hemorrhage and died hours later. Family and colleagues remember her passion and courage.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - September 24, 2020 Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news

NIH Expands Clinical Trials on Convalescent Plasma NIH Expands Clinical Trials on Convalescent Plasma
"The evidence on convalescent plasma as a treatment for severe cases of COVID-19 is promising but incomplete," said Francis S. Collins, MD, director of the National Institutes of Health.WebMD Health News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - September 24, 2020 Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news

Children ’ s Share of COVID-19 Burden Continues to Increase Children ’ s Share of COVID-19 Burden Continues to Increase
The 38,516 child cases reported during the week ending September 17 bring the cumulative number to 587,948, which is 10.3% of all COVID-19 cases.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - September 24, 2020 Category: Infectious Diseases Tags: Pediatrics News Source Type: news

Battle Rages Inside Hospitals Over How COVID Strikes and Kills Battle Rages Inside Hospitals Over How COVID Strikes and Kills
Front-line health care workers are locked in a heated dispute with many infection control specialists and hospital administrators over how the novel coronavirus is spread.Kaiser Health News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 24, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

Covid-19: is it possible to predict how sick someone could get? – podcast
Nine months in, and with over 30 million people having been infected with Covid-19, we now know some of the main factors that put people at higher risk of a severe case of the disease, such as age and having other health problems. But there is still a lot to learn about why some people, and not others, become very ill from catching Sars-CoV-2.Nicola Davis takes a look at the researchers attempting to rapidly work out how to predict who is going to get very sickContinue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 24, 2020 Category: Science Authors: Presented by Nicola Davis and produced by Madeleine Finlay Tags: Science Coronavirus outbreak Infectious diseases Medical research Biology Source Type: news

UK Covid-19 vaccine trial set to infect healthy volunteers with virus
Researchers hope to begin world ’s first human challenge trials at east London quarantine facility in JanuaryCoronavirus – latest updatesSee all our coronavirus coverageHealthy volunteers in the UK could soon be deliberately infected with coronavirus in the world ’s first human challenge trial to find out which Covid vaccines work.Government-funded studies, which it is believed will be announced next week, could begin in January in London,the Financial Times has reported. Volunteers exposed to Covid-19 would be closely monitored in strict quarantine for as long as a month.Continue reading... (Source: Guar...
Source: Guardian Unlimited Science - September 24, 2020 Category: Science Authors: Amy Walker and Sarah Boseley Tags: Coronavirus outbreak Vaccines and immunisation UK news Infectious diseases Science Medical research Health Source Type: news

Public health officials call for tighter restrictions, warn COVID-19 could spiral out of control
Infectious disease experts say Canadian health authorities must tighten restrictions again or hospitalizations and deaths from COVID-19 will increase exponentially in the coming weeks. (Source: CBC | Health)
Source: CBC | Health - September 24, 2020 Category: Consumer Health News Tags: News/Health Source Type: news

East Africa: People With This Blood Type Are Unlikely to Get Malaria
[Nation] The war against malaria just received a shot in the arm after new research should the potential a rare blood group could hold. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - September 24, 2020 Category: Infectious Diseases Source Type: news

Africa: Covid-19 and Malaria - How Surveillance Systems Can Adapt to Fight Both
[Malaria Consortium] When COVID-19 was declared a pandemic by WHO in March 2020, governments and organisations involved in the prevention and control of malaria had a choice to make - divert their attention from the diagnosis, control and prevention of malaria to that of COVID-19, or leverage the existing surveillance systems to fight both as effectively as possible. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - September 24, 2020 Category: Infectious Diseases Source Type: news

Key genetic clue missing in fight against superbugs
(Wellcome Trust Sanger Institute) For the first time, researchers have discovered how antibiotic resistance genes are spreading, at a continental scale, via bacterial plasmids in the hospital superbug, Klebsiella pneumoniae. The researchers say it is critical that plasmids are included when tracking antibiotic resistance in order to have the best chance of stopping superbugs. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 24, 2020 Category: Biology Source Type: news

Jindal school researchers examine COVID-19 impact on manufacturing
(University of Texas at Dallas) Two Jindal School faculty members found that manufacturing response to COVID-19 has been largely reactive and uncoordinated, and many firms' crisis communication plans do not include managing an infectious-disease outbreak. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 24, 2020 Category: International Medicine & Public Health Source Type: news

Accuracy of commercial antibody kits for SARS-CoV-2 varies widely
(PLOS) There is wide variation in the performance of commercial kits for detecting antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), according to a study published September 24 in the open-access journal PLOS Pathogens by Jonathan Edgeworth and Blair Merrick of Guy's and St Thomas' NHS Foundation Trust, Suzanne Pickering and Katie Doores of King's College London, and colleagues. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

Antibodies protect against wide range of influenza B virus strains
(Washington University School of Medicine) Researchers have identified two antibodies that protect mice against lethal infections of influenza B virus, report scientists at Washington University School of Medicine in St. Louis and Icahn School of Medicine at Mount Sinai. Together with an antibody that targets the other major kind of influenza viruses that infect people -- influenza A -- these antibodies potentially could form the basis of a broad-spectrum flu drug that could treat almost all flu cases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

Assessment of disparities in COVID-19 testing, infection across language groups in Seattle
(JAMA Network) Researchers evaluated the proportion of patients who completed COVID-19 testing and the proportion of positive cases using language as a surrogate for immigrant status. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

Genetic variation unlikely to influence COVID-19 morbidity and mortality
(Hokkaido University) A comprehensive search of genetic variation databases has revealed no significant differences across populations and ethnic groups in seven genes associated with viral entry of SARS-CoV-2. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

COVID-19: Berlin scientists lay basis for a passive vaccination
(DZNE - German Center for Neurodegenerative Diseases) Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charit é -- Universit ä tsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination. In this process, they have also discovered that some SARS-CoV-2 antibodies bind to tissue samples from various organs, which could potentially trigger undesired side effects. They report their findings in the scientific journal " Cell " . (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

Talc and petroleum jelly among the best lubricants for people wearing PPE
(Imperial College London) Talcum powder, a coconut oil-cocoa butter beeswax mixture, and petroleum jelly provide the best skin protection for long-term PPE use, say scientists. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

The Lancet: Experts compare strategies for easing lockdown restrictions in Europe and Asia Pacific and identify key cross-country lessons
(The Lancet) Authors of a review of policies, based on the experiences of nine high-income countries and regions' easing of lockdown measures, published in The Lancet journal, are urging governments to consider five key factors in lockdown exit strategies. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

Something old, something new combine for effective vaccine against parasitic skin disease
(Ohio State University) Scientists are planning for Phase 1 human trials of a vaccine they developed by using CRISPR gene-editing technology to mutate the parasite that causes leishmaniasis, a skin disease common in tropical regions of the world and gaining ground in the United States. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

Unusual climate conditions influenced WWI mortality and subsequent Spanish flu pandemic
(American Geophysical Union) Scientists have spotted a once-in-a-century climate anomaly during World War I that likely increased mortality during the war and the influenza pandemic in the years that followed. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

Some severe COVID-19 cases linked to genetic mutations or antibodies that attack the body
(Howard Hughes Medical Institute) Two new studies offer an explanation for why COVID-19 cases can be so variable. A subset of patients has mutations in key immunity genes; other patients have autoantibodies that target the same components of the immune system. Both circumstances could contribute to severe forms of the disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

Scientists trace severe COVID-19 to faulty genes and an autoimmune condition
(Rockefeller University) An international team led by Jean-Laurent Casanova has led to a breakthrough in understanding why only some people develop severe COVID-19: due to faulty genes or misguided antibodies, they lack type I interferons, proteins vital in protecting against viruses. The findings point to certain existing medical interventions as potentially beneficial treatments. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

Hodder, WVU team to lead $1.5 million, multi-state data project to examine COVID-19 outcomes
(West Virginia University) Dr. Sally Hodder, director of the West Virginia Clinical and Translational Science Institute headquartered at WVU, will lead an eight-state consortium that will contribute to a national COVID-19 data resource, thanks to a $1.5 million National Institutes of Health grant. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

Carriers of two genetic mutations at greater risk for illness and death from COVID-19
(American Friends of Tel Aviv University) Tel Aviv University researchers suggest that carriers of the genetic mutations PiZ and PiS are at high risk for severe illness and even death from COVID-19. These mutations lead to deficiency in the alpha1-antitrypsin protein, which protects lung tissues from damage in case of severe infections. Other studies have already associated deficiency in this protein with inflammatory damage to lung function in other diseases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

Intersecting social inequities increase the likelihood of severe illness due to COVID-19
(University of Toronto) Black, South Asian and Aboriginal populations from disadvantaged socioeconomic backgrounds in Canada are nearly four times more likely to have three or more medical conditions that have been identified as risk factors for severe illness from COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

COVID-19 infected workers return to work faster using time and symptom-based protocols
(Massachusetts General Hospital) Recently, investigators assessed the experience of using a test-based protocol in over 1000 infected health care workers. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

BIOCAD will produce the COVID-19 vaccine developed by Gamalei Institute
(BIOCAD) On September 23, 2020, the biotechnology company BIOCAD signed an agreement on the industrial production of the COVID-19 vaccine with the Research Center for Epidemiology and Microbiology of the Ministry of Health of Russia named after V. Gamaleya. BIOCAD becomes an industrial partner of the scientific center and will ensure the mass-scale production of the « Sputnik V » vaccine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

Hypercoagulability in patients with coronavirus disease (COVID-19)
(American Roentgen Ray Society) In this AJR article, 82 patients with COVID-19 who underwent abdominal ultrasound or CT were retrospectively compared with 82 patients without COVID-19 for thromboembolism and solid-organ infarction. Nine (11%) patients with COVID-19 had thromboembolic findings, with medium to large arterial thrombi in five. One patient without COVID-19 had known portal vein thrombus on CT. Thromboembolic findings occurred more frequently in patients with than without COVID-19 (p = 0.02). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

Blood-based test accurately identifies viral infection before symptoms develop
(Duke University Medical Center) A team of Duke Health scientists have identified biomarkers that accurately identify numerous viral infections across the clinical stages of disease, advancing a potential new way to guide treatment, quarantine decisions, and other clinical and public health interventions in the setting of endemic and pandemic infectious diseases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

Scientists Discover Genetic and Immunologic Underpinnings of Some Cases of Severe COVID-19
(NIH/National Institute of Allergy and Infectious Diseases) New findings by scientists at the National Institutes of Health and their collaborators help explain why some people with COVID-19 develop severe disease. The findings also may provide the first molecular explanation for why more men than women die from COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

Chikungunya – Chad
On 28 August 2020, the National IHR Focal Point of Chad notified WHO of an outbreak of chikungunya in Ab éché, eastern Chad. (Source: WHO Disease Outbreaks)
Source: WHO Disease Outbreaks - September 24, 2020 Category: Infectious Diseases Tags: news Source Type: news

Fauci, COVID Researchers on TIME's Most Influential People List Fauci, COVID Researchers on TIME's Most Influential People List
Throughout the pandemic, Fauci has been a leading voice on safety guidelines to reduce the spread of the coronavirus and on details about therapeutics and vaccines. The list of 100 also includes public health experts who have been influential during the pandemic.WebMD Health News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 24, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

Dutch daily infections hit new high – as it happened
This blog is now closed. Follow our new blog below:Coronavirus news – live11.42pmBSTWe ’ve launched a new blog at the link below – head there for the latest:Related:Coronavirus live news: Indonesia sees record case rise; India deaths pass 90,00011.42pmBSTHere ’s a quick run down of the latest global coronavirus developments over the last few hours.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 24, 2020 Category: Science Authors: Jessica Murray (now); Lucy Campbell, Damien Gayle, Nazia Parveen and Helen Sullivan (earlier) Tags: Coronavirus outbreak World news UK news Science Infectious diseases Source Type: news

The science and medicine of human immunology
Although the development of effective vaccines has saved countless lives from infectious diseases, the basic workings of the human immune system are complex and have required the development of animal models, such as inbred mice, to define mechanisms of immunity. More recently, new strategies and technologies have been developed to directly explore the human immune system with unprecedented precision. We discuss how these approaches are advancing our mechanistic understanding of human immunology and are facilitating the development of vaccines and therapeutics for infection, autoimmune diseases, and cancer. (Source: ScienceNOW)
Source: ScienceNOW - September 24, 2020 Category: Science Authors: Pulendran, B., Davis, M. M. Tags: Immunology, Online Only review Source Type: news

J & J ’ s One-Shot COVID-19 Vaccine Advances to Phase 3 Testing J & J ’ s One-Shot COVID-19 Vaccine Advances to Phase 3 Testing
Johnson& Johnson has advanced its one-shot COVID-19 vaccine into phase 3 testing. The National Institute of Allergy and Infectious Diseases describes this as the fourth candidate to reach this stage.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - September 23, 2020 Category: Primary Care Tags: Infectious Diseases News Source Type: news

Report: States Need to Track COVID-19 Data Better Report: States Need to Track COVID-19 Data Better
While all 50 states and the District of Columbia have COVID-19 data dashboards, the data reported is inconsistent, incomplete, and inaccessible in most locations.WebMD Health News (Source: Medscape PublicHealth Headlines)
Source: Medscape PublicHealth Headlines - September 23, 2020 Category: Primary Care Tags: Infectious Diseases News Source Type: news

Many Metrics to Measure COVID-19 -- Which Are Best? Many Metrics to Measure COVID-19 -- Which Are Best?
In this pandemic, there are many different metrics used to measure the situation. Each has its own usefulness and its own limits.WebMD Health News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 23, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

California's Deadliest Spring in 20 Yrs Suggests COVID Undercount California's Deadliest Spring in 20 Yrs Suggests COVID Undercount
The grim milestone encompasses thousands of'excess'deaths not accounted for in the state's official COVID death tally: a loss of life concentrated among Blacks, Asians, and Latinx.Kaiser Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - September 23, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Shortage of Naive T Cells Raises COVID-19 Risk in Elderly Shortage of Naive T Cells Raises COVID-19 Risk in Elderly
A lower supply of a certain type of immune cell in older people that is critical to fighting foreign invaders may help explain their vulnerability to severe COVID-19, scientists say.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 23, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news